Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010678

Options or other derivatives

  • Director acquired 37,882 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kunkel Lori Anne · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-08 Grant or award : show line 1 in the form Stock Option (right to buy) +37,882 37,882 D
Loading xslF345X05/form4-04112024_120413.xml…